Clinical Trials on WT1 Expressing Carcinoma in India

Total 260 results

Asian Institute of Gastroenterology, India

Recruiting

RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION (MBOP)

Bile Duct Neoplasms | Gall Bladder Carcinoma

India
Tata Memorial Hospital

Recruiting

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Cholangiocarcinoma

India
Public Health Research Institute, India
PATH

Withdrawn

Human Papillomavirus Screening and Vaccine Readiness Program

Human Papilloma Virus-Related Carcinoma

India
Dr Rajendra A. Badwe
Tata Memorial Hospital

Recruiting

Pre Operative Trastuzumab in Operable Breast Cancer

HER2 Positive Breast Cancer | Carcinoma Breast Stage I

India
Tata Medical Center

Completed

Short Course Radiotherapy for Localized Prostate Cancer (SHORT)

Adenocarcinoma of Prostate

India
Maastricht Radiation Oncology

Active, not recruiting

Personal Health Train for Radiation Oncology in India and The Netherlands (TRAIN)

Head and Neck Carcinoma

India, Netherlands
Sanjay Gandhi Postgraduate Institute of Medical...

Recruiting

Transcriptomic Signatures in Gastric Adenocarcinoma (GAC)

Gastric Adenocarcinoma

India
Asian Institute of Gastroenterology, India

Unknown

Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas

Pancreatic Cancer

India
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer (SPARK)

Squamous Cell Carcinoma of Head and Neck

India
Tata Medical Center

Completed

Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery (RIGoROCS)

Ovarian Cancer

India
Indrayani Hospital and Cancer Institute
Tata Capital Limited; Grant Medical Foundation Ruby hall Clinic

Completed

Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers

Squamous Cell Carcinoma of Oral Cavity

India
National Cancer Institute (NCI)

Completed

Improving Cervical Cancer Screening Among HIV-Infected Women in India

Cervical Cancer | Cervical Intraepithelial Neoplasia | HIV/AIDS | Biomarkers | HPV

India
Peregrine Pharmaceuticals

Completed

Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

Carcinoma Breast Stage IV

India
Rajkumar Kottayasamy Seenivasagam

Unknown

Study on Early Stage Bulky Cervical Cancers

Carcinoma Cervix

India
Tata Memorial Hospital

Completed

Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix (CRACx)

Cancer of Cervix

India
Piramal Enterprises Limited

Completed

A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer (MONARCH)

Squamous Cell Carcinoma of Head and Neck

India
Bharat Serums and Vaccines Limited

Completed

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Advanced Prostate Adenocarcinoma

India
Postgraduate Institute of Medical Education and...

Completed

Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy

Lung Diseases | Lung Cancer | Adenocarcinoma of Lung

India
GlaxoSmithKline

Completed

A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer

Squamous Cell Carcinoma of Head and Neck

Spain, France, Peru, India, Greece
Sandoz

Completed

A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With BRCA Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer

Breast Cancer | Ovarian Cancer

India
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation

Spain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
Postgraduate Institute of Medical Education and...

Terminated

Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal Carcinomatosis (ROLLON)

Ascites | Peritoneal Carcinomatosis | Peritoneum Neoplasm | Tuberculous Peritonitis

India
AstraZeneca

Completed

Osimertinib Study in Indian Patients

Non Small Cell Lung Cancer (NSCLC)

India
Postgraduate Institute of Medical Education and...

Completed

Evaluation of Two Boost Radiation Schedules in Post Lumpectomy Early Stage Carcinoma Breast

Breast Cancer | Adverse Effect of Radiation Therapy

India
Hoffmann-La Roche

Completed

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression

Non-Small Cell Lung Cancer

India
Postgraduate Institute of Medical Education and...

Completed

Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy (PEMVITASTART)

Anemia | Thrombocytopenia | Neutropenia | Lung Adenocarcinoma | Nonsquamous Nonsmall Cell Neoplasm of Lung

India
Pfizer

Completed

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

Renal Cell Carcinoma

India
Bristol-Myers Squibb

Completed

Study of Nivolumab for Advanced Cancers in India

Kidney Cancer | Kidney Neoplasms | Nonsmall Cell Lung Cancer | Renal Cancer | Non-Small-Cell Lung Carcinoma | Non-Small Cell Lung Cancer (NSCLC) | Renal Neoplasms

India
International Atomic Energy Agency
Tata Memorial Centre; University of Maryland, College Park; Centro de Lucha contra... and other collaborators

Unknown

Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial (HYPNO)

Squamous Cell Carcinoma of the Head and Neck

India, Argentina, Cuba, Indonesia, Pakistan, Philippines, South Africa, Thailand, Uruguay
AstraZeneca

Completed

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

Unresectable Non-small Cell Lung Cancer (NSCLC)

India
Eisai Pharmaceuticals India Pvt. Ltd

Completed

A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC

Carcinoma, Hepatocellular

India
Boehringer Ingelheim

Completed

Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy

Non-small Cell Lung Cancer

India
NATCO Pharma Ltd.

Recruiting

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

Carcinoma | Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

United States, India
International Atomic Energy Agency
Catholic University of the Sacred Heart; University of Cape Town; Tata Memorial... and other collaborators

Unknown

Resource-Sparing Curative Treatment for Rectal Cancer

Rectal Carcinoma

Algeria, Brazil, Canada, Colombia, Croatia, Cuba, India, Indonesia, Italy, Slovakia, South Africa
Merck Sharp & Dohme LLC

Active, not recruiting

Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)

Melanoma | Carcinoma, Non-Small-Cell Lung

India
Merck KGaA, Darmstadt, Germany
Merck Ltd., India

Terminated

A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (PMS LAD SCCHN)

Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck | LA SCCHN

India
Titan Pharmaceuticals

Completed

Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, India, United Kingdom
Cadila Pharnmaceuticals

Completed

Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder (STCC)

Bladder Cancer

India
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Not yet recruiting

Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men

HIV Infection | Human Papillomavirus Infection | Human Papillomavirus-Related Carcinoma

United States, India
Novartis Pharmaceuticals

Recruiting

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

Non-Small Cell Lung Carcinoma

India
AstraZeneca

Completed

IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma

Neoplasms, Squamous Cell

United States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
Cadila Pharnmaceuticals

Completed

Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder (STCC)

Bladder Cancer

India
SK Chemicals Co., Ltd.

Completed

Study to Evaluate SID 530 Compared to Taxotere

Non-Small Cell Lung Cancer

United States, India
AstraZeneca

Completed

Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer (SOLI)

Breast Cancer | Ovarian Cancer

India
Pfizer

Completed

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

Metastatic Non Small Cell Lung Cancer

India
Peregrine Pharmaceuticals

Completed

Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

India
Hoffmann-La Roche

Completed

A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

Renal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant Melanoma

Canada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
Pfizer

Completed

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

Advanced Non-Small Cell Lung Cancer

India
BioMarck Pharmaceuticals, Ltd.

Completed

A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer Stage IIIB

India
AstraZeneca

Completed

Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer). (CONCORDANCE)

NSCLC (Non-small Cell Lung Cancer)

India

Clinical Trials on WT1 Expressing Carcinoma in India

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations